Patents by Inventor Amalia Rossi-Campos

Amalia Rossi-Campos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Actinobacillus pleuropneumoniae outer membrane lipoprotein A and uses thereof
    Patent number: 5891677
    Abstract: Novel vaccines for use against Actinobacillus pleuropneumoniae are disclosed. The vaccines contain at least one Actinobacillus pleuropneumoniae outer membrane lipoprotein A, or an immunogenic fragment thereof. Also disclosed are DNA sequences encoding these proteins, vectors including these sequences and host cells transformed with these vectors. The vaccines can be used to treat or prevent porcine respiratory infections.
    Type: Grant
    Filed: August 15, 1995
    Date of Patent: April 6, 1999
    Assignee: University of Saskatchewan
    Inventors: Gerald F. Gerlach, Philip J. Willson, Amalia Rossi-Campos, Andrew A. Potter
  • Actinobacillus pleuropneumoniae transferrin binding protein vaccines and uses thereof
    Patent number: 5876725
    Abstract: Novel vaccines for use against Actinobacillus pleuropneumoniae are disclosed. The vaccines contain at least one A. pleuropneumoniae transferrin binding protein and/or one A. pleuropneumoniae cytolysin and/or one A. pleuropneumoniae APP4. Also disclosed are DNA sequences encoding these proteins, vectors including these sequences and host cells transformed with these vectors. The vaccines can be used to treat or prevent porcine respiratory infections.
    Type: Grant
    Filed: September 19, 1996
    Date of Patent: March 2, 1999
    Assignee: University of Saskatchewan
    Inventors: Andrew A. Potter, Gerald F. Gerlach, Philip J. Willson, Amalia Rossi-Campos
  • Vaccines for Actinobacillus pleuropneumoniae
    Patent number: 5801018
    Abstract: Novel vaccines for use against Actinobacillus pleuropneumoniae are disclosed. The vaccines contain at least one A. pleuropneumoniae transferrin binding protein and/or one A. pleuropneumoniae cytolysin and/or one A. pleuropneumoniae APP4. Also disclosed are DNA sequences encoding these proteins, vectors including these sequences and host cells transformed with these vectors. The vaccines can be used to treat or prevent porcine respiratory infections.
    Type: Grant
    Filed: October 12, 1994
    Date of Patent: September 1, 1998
    Assignee: University of Saskatchewan
    Inventors: Andrew A. Potter, Gerald F. Gerlach, Philip J. Willson, Amalia Rossi-Campos
  • Actinobacillus pleuropneumoniae transferrin binding proteins and uses thereof
    Patent number: 5521072
    Abstract: Novel vaccines for use against Actinobacillus pleuropneumoniae are disclosed. The vaccines contain at least one A. pleuropneumoniae transferrin binding protein and/or one A. pleuropneumoniae cytolysin and/or one A. pleuropneumoniae APP4. Also disclosed are DNA sequences encoding these proteins, vectors including these sequences and host cells transformed with these vectors. The vaccines can be used to treat or prevent porcine respiratory infections.
    Type: Grant
    Filed: March 22, 1994
    Date of Patent: May 28, 1996
    Assignee: University of Saskatchewan
    Inventors: Andrew A. Potter, Gerald F. Gerlach, Philip J. Willson, Amalia Rossi-Campos
  • Actinobacillus pleuropneumoniae outer membrane lipoprotein A and uses thereof
    Patent number: 5441736
    Abstract: Novel vaccines for use against Actinobacillus pleuropneumoniae are disclosed. The vaccines contain at least one Actinobacillus pleuropneumoniae outer membrane lipoprotein A, or an immunogenic fragment thereof. Also disclosed are DNA sequences encoding these proteins, vectors including these sequences and host cells transformed with these vectors. The vaccines can be used to treat or prevent porcine respiratory infections.
    Type: Grant
    Filed: November 5, 1992
    Date of Patent: August 15, 1995
    Assignee: University of Saskatchewan
    Inventors: Gerald F. Gerlach, Philip J. Willson, Amalia Rossi-Campos, Andrew A. Potter
  • Vaccines for Actinobacillus pleuropneumoniae
    Patent number: 5417971
    Abstract: Novel vaccines for use against Actinobacillus pleuropneumoniae are disclosed. The vaccines contain at least one A. pleuropneumoniae transferrin binding protein and/or one A. pleuropneumoniae cytolysin and/or one A. pleuropneumoniae APP4. Also disclosed are DNA sequences encoding these proteins, vectors including these sequences and host cells transformed with these vectors. The vaccines can be used to treat or prevent porcine respiratory infections.
    Type: Grant
    Filed: October 15, 1992
    Date of Patent: May 23, 1995
    Assignee: University of Saskatchewan
    Inventors: Andrew A. Potter, Gerald F. Gerlach, Philip J. Willson, Amalia Rossi-Campos